Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stroke Prevention in Patients With Atrial Fibrillation”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Not applicableStudy completedNCT02784717
What this trial is testing

Xarelto on Prevention of Stroke and Non-central Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in China: A Non-interventional Study

Who this might be right for
Stroke
Bayer 3,055
Not applicableStudy completedNCT01750788
What this trial is testing

Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation in Asia

Who this might be right for
Atrial Fibrillation
Bayer 2,297
Not applicableStudy completedNCT04233515
What this trial is testing

Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County

Who this might be right for
Atrial FibrillationStroke, Ischemic
Region Örebro County 11,964
Not applicableNot Yet RecruitingNCT06355986
What this trial is testing

Computerized Decision Support to Prevent Stroke in Atrial Fibrillation

Who this might be right for
Atrial FibrillationStroke
Brigham and Women's Hospital 2,500
Not applicableStudy completedNCT02640222
What this trial is testing

APIXABAN in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France SNIIRAM Study

Who this might be right for
Anticoagulation
Bristol-Myers Squibb 321,501
Not applicableStudy completedNCT03826927
What this trial is testing

New Oral Anticoagulants (NOAC) in Stroke Patients

Who this might be right for
StrokeAtrial Fibrillation
University Hospital, Basel, Switzerland 1,023
Not applicableStudy completedNCT02960880
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Rivaroxaban vs. Vitamin k Antagonists

Who this might be right for
Atrial Fibrillation
Bayer 99,999
Not applicableStudy completedNCT02597920
What this trial is testing

Patient Convenience Study

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,852
Not applicableStudy completedNCT03746301
What this trial is testing

Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 924
Not applicableUnknownNCT04180605
What this trial is testing

Computational Simulation to Plan for Percutaneous Left Atrial Appendage Closure

Who this might be right for
Atrial FibrillationStroke Prevention
Rigshospitalet, Denmark 200
Not applicableStudy completedNCT03374540
What this trial is testing

Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients

Who this might be right for
Nonvalvular Atrial Fibrillation
Bayer 78,517
Not applicableStudy completedNCT02485873
What this trial is testing

Real-Life Evidence on Stroke Prevention in SPAF

Who this might be right for
Atrial Fibrillation (Prevention of Stroke)
Bayer 8,607
Not applicableStudy completedNCT02684981
What this trial is testing

Patient Convenience Study (RE-SONANCE)

Who this might be right for
Atrial FibrillationStroke
Boehringer Ingelheim 9,472
Not applicableStudy completedNCT01871194
What this trial is testing

An Observational Post-Authorization Safety Specialist Cohort Event Monitoring Study (SCEM) to Monitor the Safety and Utilization of Rivaroxaban (Xarelto®).

Who this might be right for
Atrial FibrillationDeep Vein ThrombosisPulmonary Embolism
Professor Saad Shakir 3,400
Not applicableStudy completedNCT03847181
What this trial is testing

Study to Learn More About the Benefits and Side-effects of Drugs Rivaroxaban and Apixaban Compared to the Drug Warfarin for Stroke Prevention in Patients With Rapid and Irregular Heartbeat Which is Not Due to a Heart-valve Fault (Non-valvular Atrial Fibrillation) in the UK Routine Clinical Practice

Who this might be right for
Atrial Fibrillation
Bayer 45,164
Testing effectiveness (Phase 2)Ended earlyNCT00206063
What this trial is testing

Long Term Open Follow-up With H376/95 vs. Warfarin

Who this might be right for
Stroke Prevention in Patients With Atrial Fibrillation
AstraZeneca 220
Large-scale testing (Phase 3)Study completedNCT03273322
What this trial is testing

Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure

Who this might be right for
Atrial FibrillationAtrial AppendageHemorrhage
Assistance Publique - Hôpitaux de Paris 105
Not applicableStudy completedNCT03568916
What this trial is testing

Direct Oral Anticoagulants in Patients With Atrial Fibrillation (DOACs vs DOACs)

Who this might be right for
Atrial FibrillationIschemic StrokeSystemic Embolization+3 more
Canadian Network for Observational Drug Effect Studies, CNODES 227,579
Not applicableStudy completedNCT03187197
What this trial is testing

Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,315
Not applicableStudy completedNCT02339493
What this trial is testing

Electronic Alerts for Stroke Prevention in Patients With Atrial Fibrillation or Atrial Flutter

Who this might be right for
Atrial FibrillationStroke
Brigham and Women's Hospital 458
Load More Results